175 related articles for article (PubMed ID: 17401783)
1. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].
Martínez-Gras I; Hoecnika J; Pérez-Hernández E; Rodríguez-Jiménez R; Ponce G; Jiménez-Arriero M; Ramos-Atance J; Palomo T; Rubio G
Actas Esp Psiquiatr; 2007; 35(2):122-9. PubMed ID: 17401783
[TBL] [Abstract][Full Text] [Related]
2. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
3. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
[TBL] [Abstract][Full Text] [Related]
4. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the endocannabinoid system.
Norrod AG; Puffenbarger RA
Chem Biodivers; 2007 Aug; 4(8):1926-32. PubMed ID: 17712834
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
Müller-Vahl KR; Emrich HM
Expert Rev Neurother; 2008 Jul; 8(7):1037-48. PubMed ID: 18590475
[TBL] [Abstract][Full Text] [Related]
7. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of the endocannabinoid system and drug addiction in humans.
López-Moreno JA; Echeverry-Alzate V; Bühler KM
J Psychopharmacol; 2012 Jan; 26(1):133-43. PubMed ID: 21937688
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system: emotion, learning and addiction.
Moreira FA; Lutz B
Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
12. Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system.
El Rawas R; Thiriet N; Nader J; Lardeux V; Jaber M; Solinas M
Brain Res; 2011 May; 1390():80-9. PubMed ID: 21419109
[TBL] [Abstract][Full Text] [Related]
13. The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.
Dinu IR; Popa SG; Moţa M; Moţa E; Stănciulescu C; Ioana M; Cruce M
Rom J Morphol Embryol; 2011; 52(3):791-5. PubMed ID: 21892520
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia.
Leweke FM
Curr Top Behav Neurosci; 2009; 1():387-96. PubMed ID: 21104393
[TBL] [Abstract][Full Text] [Related]
15. Role of cannabis and endocannabinoids in the genesis of schizophrenia.
Fernandez-Espejo E; Viveros MP; Núñez L; Ellenbroek BA; Rodriguez de Fonseca F
Psychopharmacology (Berl); 2009 Nov; 206(4):531-49. PubMed ID: 19629449
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system and neurogenesis in health and disease.
Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
Neuroscientist; 2007 Apr; 13(2):109-14. PubMed ID: 17404371
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
18. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia.
Ujike H; Morita Y
J Pharmacol Sci; 2004 Dec; 96(4):376-81. PubMed ID: 15613777
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
[TBL] [Abstract][Full Text] [Related]
20. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.
Martínez-Gras I; Hoenicka J; Ponce G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Pérez-Hernandez E; Ampuero I; Ramos-Atance JA; Palomo T; Rubio G
Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):437-41. PubMed ID: 16788767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
